secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telesis Bio Inc. (—)
CIK:        0001850079
Form:       8-K
Filed at:   2023-11-30T23:59:59+00:00
Accession:  0000950170-23-067073
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Telesis Bio waives default, prepays $15M debt; Nasdaq warns of bid price delisting risk
--------------------------------------------------------------------------------

- Entered Third Amendments waiving existing event of default under term and revolving loan agreements.
- Required prepayment of $15M of term loans; prepayment fees waived. Minimum net revenue covenants amended.
- Revolving loan fees waived as long as no borrowings outstanding; future borrowing subject to lender consent.
- Received Nasdaq notice for non-compliance with minimum bid price of $1.00; 180-day cure period until May 22, 2024.
- If not cured, may seek additional 180 days by meeting other listing standards and effecting reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850079/000095017023067073/0000950170-23-067073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850079/000095017023067073/tbio-20231124.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-067073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer